typical microdose of tirzepatide 3- Month Micro-dosing Microdose Tirzepatide | Peptide Therapy

Some studies indicate that certain peptide formulations may remain stable for up to three months under optimal conditions, though conservative estimates of six to eight weeks represent a safer standard for pharmaceutical and clinical applications where patient safety and treatment efficacy are paramount

Intramuscular injection increases risk of rapid absorption, which may trigger severe nausea, vomiting, or hypoglycemiaespecially if you're fasting or have diabetes

Eli Lillys oral version, orforglipron, is still in trials as of June 2026

Muscle loss: Semaglutide has been associated with the loss of lean body mass (muscle and bone), accounting for up to 40 percent of total weight loss